Xvivo Perfusion AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	308.14	292.09	415.52	546.09	246.55	398.7
Cash & Short-Term Investments	308.14	292.09	415.52	546.09	246.55	398.7
Cash Growth	-2.45%	-29.70%	-23.91%	121.50%	-38.16%	12.55%
Accounts Receivable	189.33	101.34	117.29	98.13	94.5	52.04
Other Receivables	-	17.48	23.74	20.25	9.76	11.88
Receivables	189.33	118.82	141.04	118.37	104.26	63.91
Inventory	227.22	248.46	227.41	141.6	106.57	77.59
Prepaid Expenses	-	28.85	29.11	20.34	10.14	7.34
Total Current Assets	724.69	688.21	813.08	826.41	467.51	547.53
Property, Plant & Equipment	215.16	213.88	149.04	97.55	47.58	26.3
Long-Term Investments	-	0.63	0.9	0.58	0.41	1.16
Goodwill	622.98	610.06	682.48	591.39	625.32	460.23
Other Intangible Assets	38.95	39.61	48.7	30.46	8.49	8.66
Long-Term Deferred Tax Assets	-	21.04	32.45	50.71	39.27	42.17
Long-Term Deferred Charges	840.03	800.68	676.09	598.51	544.51	456.55
Total Assets	2,469	2,374	2,403	2,196	1,733	1,543
Accounts Payable	-	31.5	39.45	36.05	38.47	21.45
Accrued Expenses	-	47.54	85.08	68.94	52.65	46.96
Current Portion of Leases	11.36	11.56	10.92	10.27	5.55	4.2
Current Income Taxes Payable	-	6.62	11.93	11.87	1.28	0.3
Current Unearned Revenue	-	11.62	13.47	3.69	3.17	3.01
Other Current Liabilities	149	10.53	16.67	3.66	33.77	28.6
Total Current Liabilities	160.36	119.38	177.51	134.49	134.9	104.52
Long-Term Leases	111.32	113.17	23.13	21.17	4.46	1.52
Long-Term Deferred Tax Liabilities	-	26.24	27.85	29.29	25.77	25.08
Other Long-Term Liabilities	27.92	1.87	17.48	65.62	137.83	126.02
Total Liabilities	299.6	260.65	245.97	250.57	302.95	257.15
Common Stock	0.82	0.82	0.81	0.81	0.76	0.75
Additional Paid-In Capital	1,791	1,785	1,772	1,764	1,314	1,253
Retained Earnings	353.2	316.91	291.76	119.57	27.75	9.28
Comprehensive Income & Other	24.29	10.65	92.19	60.89	87.78	22.09
Shareholders' Equity	2,169	2,113	2,157	1,945	1,430	1,285
Total Liabilities & Equity	2,469	2,374	2,403	2,196	1,733	1,543
Total Debt	122.68	124.72	34.04	31.44	10.01	5.72
Net Cash (Debt)	185.46	167.37	381.48	514.65	236.54	392.98
Net Cash Growth	-35.28%	-56.13%	-25.88%	117.58%	-39.81%	13.24%
Net Cash Per Share	5.87	5.30	12.05	17.19	8.01	13.58
Filing Date Shares Outstanding	31.5	31.5	31.5	31.5	29.83	29.5
Total Common Shares Outstanding	31.5	31.5	31.5	31.5	29.83	29.5
Working Capital	564.32	568.83	635.57	691.92	332.61	443.01
Book Value Per Share	68.87	67.10	68.47	61.75	47.94	43.58
Tangible Book Value	1,507	1,464	1,426	1,323	796.33	816.56
Tangible Book Value Per Share	47.86	46.47	45.26	42.01	26.69	27.68
Machinery	-	307.41	217.57	153.61	98.52	68.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.